VitriVax Receives $5M Grant for Vaccine Development
VitriVax, Inc ., a formulation technology company, announced today a $5M two-year grant from the Bill & Melinda Gates Foundation.
VitriVax Receives $5M Grant for Vaccine Development Read More »
Uncategorized
Syros Announces Encouraging Initial Data from Randomized SELECT-AML-1 Phase 2 Clinical Trial Evaluating Tamibarotene in Combination with Venetoclax and Azacitidine
Syros Pharmaceuticals today announced strong and encouraging initial data from its ongoing SELECT-AML-1 Phase 2 trial evaluating tamibarotene, an oral, selective, retinoic acid receptor alpha (RARα) agonist.
Abcuro Appoints Mark Pruzanski, M.D., as Chairman of its Board of Directors
Abcuro, Inc. today announced the appointment of Mark Pruzanski, M.D., as Chairman of its Board of Directors.
Abcuro Appoints Mark Pruzanski, M.D., as Chairman of its Board of Directors Read More »
Marengo Therapeutics Announces Publication Describing STAR0602, a Novel, TCR-Targeting Cancer Immunotherapy, in Science Translational Medicine
Marengo Therapeutics, Inc. today announced that its lead program, STAR0602, is the subject of an article published in the latest edition of Science Translational Medicine.
NAYA Biosciences and ONK Therapeutics Announce Research Partnership to Advance Combination Therapy of FLEX-NK™ Bispecific Antibodies and Optimally Engineered Off-the-Shelf Natural Killer Cell Therapies
NAYA Biosciences and ONK Therapeutics to assess proof-of-concept and establish activity and feasibility of the combination of NAYA’s FLEX-NK™ bispecific antibodies.
Coya Therapeutics, Inc. and Dr. Reddy’s Laboratories Enter into an Exclusive Collaboration for Development and Commercialization of COYA 302, an Investigational Combination Therapy for Treatment of Amyotrophic Lateral Sclerosis (ALS)
Dr. Reddy’s Laboratories SA and Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya”), today announced that they have entered into a development and license agreement (the “Agreement”) for the development and commercialization of COYA 302.
Taiwan Bio and TRACT Therapeutics, Inc. Announce Strategic Partnership to Advance a Novel Therapeutic Approach for Preventing Rejection in Solid Organ Transplant
Taiwan Bio and TRACT Therapeutics are pleased to announce a new strategic partnership to advance a cellular therapy to revolutionize the prevention of allograft rejection in solid organ transplant.
Veteran’s lawsuit alleges VA Oracle EHR delayed cancer diagnosis
The suit alleges an army veteran’s diagnosis was held up for months due to errors with the electronic health record.
Veteran’s lawsuit alleges VA Oracle EHR delayed cancer diagnosis Read More »
Bering Secures FDA Clearance for AI-Based Chest X-Ray Triage Solution
Bering Limited, a London -based medical AI company, today announced it received US Food and Drug Administration (FDA) 510(k) clearance for its AI-powered chest X-Ray triage solution, ‘BraveCX’.
Bering Secures FDA Clearance for AI-Based Chest X-Ray Triage Solution Read More »
Sen. Bill Cassidy Eyes Legislation to Improve Access to Gene Therapies
With the biopharma industry’s looming wave of gene therapy submissions and potential approvals, the senior senator is laying the groundwork for a legislative initiative to improve access to these expensive treatments.
Sen. Bill Cassidy Eyes Legislation to Improve Access to Gene Therapies Read More »